Summary

The global Eye Disease Stem Cell Therapy market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
In 2025, the North America Eye Disease Stem Cell Therapy market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Eye Disease Stem Cell Therapy include Lineage Cell Therapeutics, Astellas Pharma, Riken, Sumitomo Chemical, Senju Pharmaceutical, Healios, Centre National de la Recherche Scientifique, Mayo Clinic, Intellia Therapeutics, Neurotech USA, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Eye Disease Stem Cell Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Lineage Cell Therapeutics
Astellas Pharma
Riken
Sumitomo Chemical
Senju Pharmaceutical
Healios
Centre National de la Recherche Scientifique
Mayo Clinic
Intellia Therapeutics
Neurotech USA
Ecole Normale Supérieure de Paris
Eyestem Research
EyeCyte
Segment by Type
Autologous
Allogeneic
Segment by Application
Preclinical
Clinical Phase 1,2
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Eye Disease Stem Cell Therapy market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Eye Disease Stem Cell Therapy value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Preclinical
1.3.3 Clinical Phase 1,2
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Eye Disease Stem Cell Therapy Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Eye Disease Stem Cell Therapy Market Share by Revenue, by Region (2021-2026)
2.4 Global Eye Disease Stem Cell Therapy Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Eye Disease Stem Cell Therapy Market Size and Prospective (2021-2032)
2.5.2 Europe Eye Disease Stem Cell Therapy Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Eye Disease Stem Cell Therapy Market Size and Prospective (2021-2032)
2.5.4 Latin America Eye Disease Stem Cell Therapy Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Eye Disease Stem Cell Therapy Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Eye Disease Stem Cell Therapy Historical Market Size by Type (2021-2026)
3.2 Global Eye Disease Stem Cell Therapy Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Eye Disease Stem Cell Therapy

4 Breakdown Data by Application
4.1 Global Eye Disease Stem Cell Therapy Historical Market Size by Application (2021-2026)
4.2 Global Eye Disease Stem Cell Therapy Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Eye Disease Stem Cell Therapy Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Eye Disease Stem Cell Therapy Players by Revenue (2021-2026)
5.1.2 Global Eye Disease Stem Cell Therapy Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Eye Disease Stem Cell Therapy Revenue
5.4 Global Eye Disease Stem Cell Therapy Market Concentration Analysis
5.4.1 Global Eye Disease Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Eye Disease Stem Cell Therapy Revenue in 2025
5.5 Global Key Players of Eye Disease Stem Cell Therapy Head Offices and Areas Served
5.6 Global Key Players of Eye Disease Stem Cell Therapy, Product and Application
5.7 Global Key Players of Eye Disease Stem Cell Therapy, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Eye Disease Stem Cell Therapy Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Eye Disease Stem Cell Therapy Market Size by Type (2021-2026)
6.1.2.2 North America Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Eye Disease Stem Cell Therapy Market Size by Application (2021-2026)
6.1.3.2 North America Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
6.1.4 North America Eye Disease Stem Cell Therapy Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Eye Disease Stem Cell Therapy Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Eye Disease Stem Cell Therapy Market Size by Type (2021-2026)
6.2.2.2 Europe Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Eye Disease Stem Cell Therapy Market Size by Application (2021-2026)
6.2.3.2 Europe Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
6.2.4 Europe Eye Disease Stem Cell Therapy Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Eye Disease Stem Cell Therapy Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Eye Disease Stem Cell Therapy Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Eye Disease Stem Cell Therapy Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Eye Disease Stem Cell Therapy Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Eye Disease Stem Cell Therapy Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Eye Disease Stem Cell Therapy Market Size by Type (2021-2026)
6.4.2.2 Latin America Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Eye Disease Stem Cell Therapy Market Size by Application (2021-2026)
6.4.3.2 Latin America Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
6.4.4 Latin America Eye Disease Stem Cell Therapy Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Eye Disease Stem Cell Therapy Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Eye Disease Stem Cell Therapy Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Eye Disease Stem Cell Therapy Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Eye Disease Stem Cell Therapy Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 Lineage Cell Therapeutics
7.1.1 Lineage Cell Therapeutics Company Details
7.1.2 Lineage Cell Therapeutics Business Overview
7.1.3 Lineage Cell Therapeutics Eye Disease Stem Cell Therapy Introduction
7.1.4 Lineage Cell Therapeutics Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.1.5 Lineage Cell Therapeutics Recent Development
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Details
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Eye Disease Stem Cell Therapy Introduction
7.2.4 Astellas Pharma Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.2.5 Astellas Pharma Recent Development
7.3 Riken
7.3.1 Riken Company Details
7.3.2 Riken Business Overview
7.3.3 Riken Eye Disease Stem Cell Therapy Introduction
7.3.4 Riken Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.3.5 Riken Recent Development
7.4 Sumitomo Chemical
7.4.1 Sumitomo Chemical Company Details
7.4.2 Sumitomo Chemical Business Overview
7.4.3 Sumitomo Chemical Eye Disease Stem Cell Therapy Introduction
7.4.4 Sumitomo Chemical Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.4.5 Sumitomo Chemical Recent Development
7.5 Senju Pharmaceutical
7.5.1 Senju Pharmaceutical Company Details
7.5.2 Senju Pharmaceutical Business Overview
7.5.3 Senju Pharmaceutical Eye Disease Stem Cell Therapy Introduction
7.5.4 Senju Pharmaceutical Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.5.5 Senju Pharmaceutical Recent Development
7.6 Healios
7.6.1 Healios Company Details
7.6.2 Healios Business Overview
7.6.3 Healios Eye Disease Stem Cell Therapy Introduction
7.6.4 Healios Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.6.5 Healios Recent Development
7.7 Centre National de la Recherche Scientifique
7.7.1 Centre National de la Recherche Scientifique Company Details
7.7.2 Centre National de la Recherche Scientifique Business Overview
7.7.3 Centre National de la Recherche Scientifique Eye Disease Stem Cell Therapy Introduction
7.7.4 Centre National de la Recherche Scientifique Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.7.5 Centre National de la Recherche Scientifique Recent Development
7.8 Mayo Clinic
7.8.1 Mayo Clinic Company Details
7.8.2 Mayo Clinic Business Overview
7.8.3 Mayo Clinic Eye Disease Stem Cell Therapy Introduction
7.8.4 Mayo Clinic Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.8.5 Mayo Clinic Recent Development
7.9 Intellia Therapeutics
7.9.1 Intellia Therapeutics Company Details
7.9.2 Intellia Therapeutics Business Overview
7.9.3 Intellia Therapeutics Eye Disease Stem Cell Therapy Introduction
7.9.4 Intellia Therapeutics Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.9.5 Intellia Therapeutics Recent Development
7.10 Neurotech USA
7.10.1 Neurotech USA Company Details
7.10.2 Neurotech USA Business Overview
7.10.3 Neurotech USA Eye Disease Stem Cell Therapy Introduction
7.10.4 Neurotech USA Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.10.5 Neurotech USA Recent Development
7.11 Ecole Normale Supérieure de Paris
7.11.1 Ecole Normale Supérieure de Paris Company Details
7.11.2 Ecole Normale Supérieure de Paris Business Overview
7.11.3 Ecole Normale Supérieure de Paris Eye Disease Stem Cell Therapy Introduction
7.11.4 Ecole Normale Supérieure de Paris Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.11.5 Ecole Normale Supérieure de Paris Recent Development
7.12 Eyestem Research
7.12.1 Eyestem Research Company Details
7.12.2 Eyestem Research Business Overview
7.12.3 Eyestem Research Eye Disease Stem Cell Therapy Introduction
7.12.4 Eyestem Research Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.12.5 Eyestem Research Recent Development
7.13 EyeCyte
7.13.1 EyeCyte Company Details
7.13.2 EyeCyte Business Overview
7.13.3 EyeCyte Eye Disease Stem Cell Therapy Introduction
7.13.4 EyeCyte Revenue in Eye Disease Stem Cell Therapy Business (2021-2026)
7.13.5 EyeCyte Recent Development

8 Eye Disease Stem Cell Therapy Market Dynamics
8.1 Eye Disease Stem Cell Therapy Industry Trends
8.2 Eye Disease Stem Cell Therapy Market Drivers
8.3 Eye Disease Stem Cell Therapy Market Challenges
8.4 Eye Disease Stem Cell Therapy Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Eye Disease Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Eye Disease Stem Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Eye Disease Stem Cell Therapy Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Eye Disease Stem Cell Therapy Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Eye Disease Stem Cell Therapy Revenue Share by Region (2021-2026)
Table 6. Global Eye Disease Stem Cell Therapy Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Eye Disease Stem Cell Therapy Revenue Share Forecast by Region (2027-2032)
Table 8. Global Eye Disease Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Eye Disease Stem Cell Therapy Market Share by Revenue, by Type (2021-2026)
Table 10. Global Eye Disease Stem Cell Therapy Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Eye Disease Stem Cell Therapy Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Eye Disease Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Eye Disease Stem Cell Therapy Market Share by Revenue, by Application (2021-2026)
Table 15. Global Eye Disease Stem Cell Therapy Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Eye Disease Stem Cell Therapy Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Eye Disease Stem Cell Therapy Applications
Table 18. Global Eye Disease Stem Cell Therapy Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Eye Disease Stem Cell Therapy Market Share by Players (2021-2026)
Table 20. Global Top Eye Disease Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Disease Stem Cell Therapy as of 2025)
Table 21. Ranking of Global Top Eye Disease Stem Cell Therapy Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Eye Disease Stem Cell Therapy Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Eye Disease Stem Cell Therapy, Headquarters and Area Served
Table 24. Global Key Players of Eye Disease Stem Cell Therapy, Product and Application
Table 25. Global Key Players of Eye Disease Stem Cell Therapy, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Eye Disease Stem Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Eye Disease Stem Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 29. North America Eye Disease Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Eye Disease Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Eye Disease Stem Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Eye Disease Stem Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Eye Disease Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Eye Disease Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Eye Disease Stem Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Eye Disease Stem Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Eye Disease Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Eye Disease Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Eye Disease Stem Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Eye Disease Stem Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Eye Disease Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Eye Disease Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Eye Disease Stem Cell Therapy Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Eye Disease Stem Cell Therapy Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Eye Disease Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Eye Disease Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 47. Lineage Cell Therapeutics Company Details
Table 48. Lineage Cell Therapeutics Business Overview
Table 49. Lineage Cell Therapeutics Eye Disease Stem Cell Therapy Product
Table 50. Lineage Cell Therapeutics Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 51. Lineage Cell Therapeutics Recent Development
Table 52. Astellas Pharma Company Details
Table 53. Astellas Pharma Business Overview
Table 54. Astellas Pharma Eye Disease Stem Cell Therapy Product
Table 55. Astellas Pharma Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 56. Astellas Pharma Recent Development
Table 57. Riken Company Details
Table 58. Riken Business Overview
Table 59. Riken Eye Disease Stem Cell Therapy Product
Table 60. Riken Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 61. Riken Recent Development
Table 62. Sumitomo Chemical Company Details
Table 63. Sumitomo Chemical Business Overview
Table 64. Sumitomo Chemical Eye Disease Stem Cell Therapy Product
Table 65. Sumitomo Chemical Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 66. Sumitomo Chemical Recent Development
Table 67. Senju Pharmaceutical Company Details
Table 68. Senju Pharmaceutical Business Overview
Table 69. Senju Pharmaceutical Eye Disease Stem Cell Therapy Product
Table 70. Senju Pharmaceutical Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 71. Senju Pharmaceutical Recent Development
Table 72. Healios Company Details
Table 73. Healios Business Overview
Table 74. Healios Eye Disease Stem Cell Therapy Product
Table 75. Healios Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 76. Healios Recent Development
Table 77. Centre National de la Recherche Scientifique Company Details
Table 78. Centre National de la Recherche Scientifique Business Overview
Table 79. Centre National de la Recherche Scientifique Eye Disease Stem Cell Therapy Product
Table 80. Centre National de la Recherche Scientifique Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 81. Centre National de la Recherche Scientifique Recent Development
Table 82. Mayo Clinic Company Details
Table 83. Mayo Clinic Business Overview
Table 84. Mayo Clinic Eye Disease Stem Cell Therapy Product
Table 85. Mayo Clinic Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 86. Mayo Clinic Recent Development
Table 87. Intellia Therapeutics Company Details
Table 88. Intellia Therapeutics Business Overview
Table 89. Intellia Therapeutics Eye Disease Stem Cell Therapy Product
Table 90. Intellia Therapeutics Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 91. Intellia Therapeutics Recent Development
Table 92. Neurotech USA Company Details
Table 93. Neurotech USA Business Overview
Table 94. Neurotech USA Eye Disease Stem Cell Therapy Product
Table 95. Neurotech USA Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 96. Neurotech USA Recent Development
Table 97. Ecole Normale Supérieure de Paris Company Details
Table 98. Ecole Normale Supérieure de Paris Business Overview
Table 99. Ecole Normale Supérieure de Paris Eye Disease Stem Cell Therapy Product
Table 100. Ecole Normale Supérieure de Paris Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 101. Ecole Normale Supérieure de Paris Recent Development
Table 102. Eyestem Research Company Details
Table 103. Eyestem Research Business Overview
Table 104. Eyestem Research Eye Disease Stem Cell Therapy Product
Table 105. Eyestem Research Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 106. Eyestem Research Recent Development
Table 107. EyeCyte Company Details
Table 108. EyeCyte Business Overview
Table 109. EyeCyte Eye Disease Stem Cell Therapy Product
Table 110. EyeCyte Revenue in Eye Disease Stem Cell Therapy Business (2021-2026) & (US$ Million)
Table 111. EyeCyte Recent Development
Table 112. Eye Disease Stem Cell Therapy Market Trends
Table 113. Eye Disease Stem Cell Therapy Market Drivers
Table 114. Eye Disease Stem Cell Therapy Market Challenges
Table 115. Eye Disease Stem Cell Therapy Market Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List of Figures
Figure 1. Eye Disease Stem Cell Therapy Product Picture
Figure 2. Global Eye Disease Stem Cell Therapy Market Share by Type: 2025 vs 2032
Figure 3. Autologous Features
Figure 4. Allogeneic Features
Figure 5. Global Eye Disease Stem Cell Therapy Market Share by Application: 2025 vs 2032
Figure 6. Preclinical
Figure 7. Clinical Phase 1,2
Figure 8. Eye Disease Stem Cell Therapy Report Years Considered
Figure 9. Global Eye Disease Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 10. Global Eye Disease Stem Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Eye Disease Stem Cell Therapy Market Share by Revenue, by Region: 2021 vs 2025
Figure 12. North America Eye Disease Stem Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 13. Europe Eye Disease Stem Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 14. Asia-Pacific Eye Disease Stem Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Latin America Eye Disease Stem Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Middle East & Africa Eye Disease Stem Cell Therapy Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Global Eye Disease Stem Cell Therapy Market Share by Players in 2025
Figure 18. Global Top Eye Disease Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Disease Stem Cell Therapy as of 2025)
Figure 19. The Top 10 and 5 Players Market Share by Eye Disease Stem Cell Therapy Revenue in 2025
Figure 20. North America Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
Figure 21. North America Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
Figure 22. Europe Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
Figure 23. Europe Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
Figure 24. Asia-Pacific Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
Figure 25. Asia-Pacific Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
Figure 26. Latin America Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
Figure 27. Latin America Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
Figure 28. Middle East & Africa Eye Disease Stem Cell Therapy Market Share by Type (2021-2026)
Figure 29. Middle East & Africa Eye Disease Stem Cell Therapy Market Share by Application (2021-2026)
Figure 30. Lineage Cell Therapeutics Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 31. Astellas Pharma Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 32. Riken Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 33. Sumitomo Chemical Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 34. Senju Pharmaceutical Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 35. Healios Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 36. Centre National de la Recherche Scientifique Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 37. Mayo Clinic Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 38. Intellia Therapeutics Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 39. Neurotech USA Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 40. Ecole Normale Supérieure de Paris Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 41. Eyestem Research Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 42. EyeCyte Revenue Growth Rate in Eye Disease Stem Cell Therapy Business (2021-2026)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed